Ranitidine and Impulsive behaviour - a phase IV clinical study of FDA data

Summary:

Impulsive behaviour is reported as a side effect among people who take Ranitidine (ranitidine), especially for people who are male, 50-59 old, also take Metformin, and have Stress and anxiety.

The phase IV clinical study analyzes which people have Impulsive behaviour when taking Ranitidine. It is created by eHealthMe based on reports of 233,168 people who have side effects when taking Ranitidine from the FDA, and is updated regularly.

What is Ranitidine?

Ranitidine has active ingredients of ranitidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 234,474 Ranitidine users. Check the latest studies of Ranitidine.

What is Impulsive behaviour?

Impulsive behaviour is found to be associated with 587 drugs and 576 conditions by eHealthMe. Check the latest studies of Impulsive behaviour.

On Nov, 22, 2025

233,168 people reported to have side effects when taking Ranitidine.
Among them, 21 people (0.01%) have Impulsive behaviour.

Could Ranitidine cause Impulsive behaviour?

Among these 21 people:

What is the gender of people who have Impulsive behaviour when taking Ranitidine? *

female: 38.89 %
male: 61.11 %

What is the age of people who have Impulsive behaviour when taking Ranitidine? *

What are other drugs people take besides Ranitidine? *

What are other side effects people have besides Impulsive behaviour? *

Stress And Anxiety: 8 people, 38.10%
Headache (pain in head): 8 people, 38.10%
Weight Increased: 6 people, 28.57%
Irritability: 6 people, 28.57%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 6 people, 28.57%
Depression: 5 people, 23.81%
Mood Swings (an extreme or rapid change in mood): 5 people, 23.81%
Anger: 4 people, 19.05%
Insomnia (sleeplessness): 4 people, 19.05%
Night Sweats (sweating in night): 4 people, 19.05%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 4 people, 19.05%
Stress And Anxiety: 4 people, 19.05%
Genital Herpes (herpes infection of genital): 3 people, 14.29%
Burkitt Lymphoma (cancer of the lymphatic system): 3 people, 14.29%
Depression: 3 people, 14.29%
Pain: 2 people, 9.52%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 9.52%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 1 person, 4.76%
Blood Pressure Abnormal: 1 person, 4.76%
Cardiac Disorder: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Ranitidine and have Impulsive behaviour?

- Check whether Impulsive behaviour is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ranitidine:

Ranitidine (234,474 reports)

Browse all side effects of Ranitidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Impulsive behaviour:

Impulsive behaviour (587 drugs)

Browse all the conditions that are associated with Impulsive behaviour:

Impulsive behaviour (576 conditions)

Drugs similar to Ranitidine and Impulsive behaviour :

How the study uses the data?

The study uses data from the FDA. It is based on ranitidine (the active ingredients of Ranitidine) and Ranitidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.